CVE:VIR - Viridium Pacific Group Stock Price, News & Analysis

Today's Range N/A
50-Day Range
C$0.38
MA: C$0.38
C$0.38
52-Week Range N/A
Volume26,500 shs
Average Volume92,632 shs
Market CapitalizationC$37.54 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone604-837-8688

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$1.09 million
Book ValueC$0.29 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$37.54 million
Next Earnings DateN/A
OptionableNot Optionable

Receive VIR News and Ratings via Email

Sign-up to receive the latest news and ratings for VIR and its competitors with MarketBeat's FREE daily newsletter.


Viridium Pacific Group (CVE:VIR) Frequently Asked Questions

What is Viridium Pacific Group's stock symbol?

Viridium Pacific Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VIR."

Has Viridium Pacific Group been receiving favorable news coverage?

News articles about VIR stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Viridium Pacific Group earned a coverage optimism score of 0.9 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Viridium Pacific Group.

Who are some of Viridium Pacific Group's key competitors?

What other stocks do shareholders of Viridium Pacific Group own?

Who are Viridium Pacific Group's key executives?

Viridium Pacific Group's management team includes the folowing people:
  • Mr. Jay Garnett, Pres, CEO & Director (Age 50)
  • Mr. Jarrett Malnarick, Sr. VP, COO & Director (Age 46)
  • Ms. Sze Wan Wong C.A., CPA, CA, CPA, Corp. Sec. & Strategic Advisor (Age 45)
  • Ms. Kamini Hitkari, Chief Financial Officer
  • Mr. Bob Howard, Exec. Officer

How do I buy shares of Viridium Pacific Group?

Shares of VIR and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How big of a company is Viridium Pacific Group?

Viridium Pacific Group has a market capitalization of C$0.00 and generates C$1.09 million in revenue each year. View Additional Information About Viridium Pacific Group.

What is Viridium Pacific Group's official website?

The official website for Viridium Pacific Group is http://www.viridiumpacific.com/.

How can I contact Viridium Pacific Group?

The company can be reached via phone at 604-837-8688.


MarketBeat Community Rating for Viridium Pacific Group (CVE VIR)

Community Ranking:  3.8 out of 5 (star star star)
Outperform Votes:  33 (Vote Outperform)
Underperform Votes:  11 (Vote Underperform)
Total Votes:  44
MarketBeat's community ratings are surveys of what our community members think about Viridium Pacific Group and other stocks. Vote "Outperform" if you believe VIR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VIR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/15/2019 by MarketBeat.com Staff

Featured Article: Marijuana Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel